Le Lézard
Classified in: Health, Business
Subject: LAW

Lawsuit Filed to Stop Malicious 'Health Plan' Marketing Scheme that Preyed on Vulnerable People

SANTA MONICA, Calif., July 29, 2021 /PRNewswire/ -- Vulnerable Americans who needed comprehensive medical insurance were fooled into buying limited healthcare plans that didn't meet their needs by a group of insurance agencies that used misleading advertising, according to a new federal lawsuit filed by California-based McLaren Insurance Solutions. The lawsuit alleges that Insurance Care Direct (ICD) and its various business entities engaged in a malicious scheme that hurt families and individuals. Insurance Care Direct claims to be one of the nation's largest health and life insurance agencies.

Filed July 27, 2021, in the United States District Court for the District of California, the complaint (Case 2:21-cv-06066) describes a scheme hinged on false and deceptive advertising. Families and individuals looking to purchase healthcare coverage were led to believe they would be receiving comprehensive health insurance through reputable insurers like Humana, Blue Cross/Blue Shield, United Healthcare, Cigna, Aetna, or others. But instead, the ICD scheme forced nearly every person who reached to purchase a limited benefit plan that exposed the consumers to the risk of being under- or un-insured.

"ICD used deceptive and misleading marketing tactics to rip people off," said Jim Gale, one of the attorneys representing the plaintiffs. "This wasn't about getting people coverage. This was about ICD making money and padding its pockets on the backs of unsuspecting victims."

The lawsuit alleges the people who bought these policies were carefully and deliberately targeted and deceived by ICD.

"Limited healthcare benefit plans can be right for many people," said Gale. "But they are not the same as comprehensive plans, and ICD and its many pseudonym entities simply deceived people through its advertising and marketing."

The ICD scheme involved operating websites under unregistered fictitious names, such as "Affordable Healthcare of California." Unwary consumers would go to these sites that were filled with logos from well-known insurance carriers. Seeing these familiar companies, consumers would believe they were on a trustworthy website selling quality healthcare plans.

Consumers were then directed to share their personal information, including a phone number and email address, to receive "instant health plan quotes." But instead of seeing a quote, they would receive a phone call from an agent who would then force the consumer into a limited benefit plan when they thought they were buying a comprehensive plan that would provide full healthcare coverage.

"As we detail in our lawsuit, ICD is a well-oiled marketing machine that takes advantage of people who are vulnerable," said Gale. "It's a classic bait-and-switch."

In fact, in a recent bulletin, the Texas Department of Insurance warned insurance companies, agents, and marketers of discount health care programs, that this type of activity could lead to cease and desist orders, fines, suspensions, as well as possible criminal referrals.

The lawsuit also explains how ICD hired well-connected former politicians to escape regulatory scrutiny, such as former United States Senator and Governor of Nebraska, E. Benjamin Nelson and former Oklahoma Insurance Commissioner, John Doak.

In addition to the false advertising and unfair competition alleged in the complaint, ICD conducted their insurance business without a registered agent, which is a direct violation of insurance regulations. In fact, the person designated as the company's agent admitted under oath that he was just a "figurehead."

Attorneys for McLaren have already heard from many victims of this scheme and expect to hear from more. If you suspect you are a victim, email ICDfraud@mclarenins.com.

Attorneys for McLaren are available for comment upon request.

SOURCE McLaren Insurance Solutions

These press releases may also interest you

at 16:15
The "Global Pharmaceutical Glass Packaging Market Size, Share & Trends Analysis Report by Product (Vials, Bottles, Cartridges & Syringes, Ampoules), by Drug Type (Generic, Branded, Biologic), by Region, and Segment Forecasts, 2021-2028" report has...

at 16:15
Mirati Therapeutics, Inc. , a clinical-stage targeted oncology company, today announced that in connection with the hiring, announced on September 20, 2021, of David Meek as Chief Executive Officer, Mr. Meek received an inducement award to purchase...

at 16:10
Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the grant of options to purchase 450,000 shares of its common stock and the grant of 150,000 restricted stock units (RSUs)...

at 16:10
Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, today announced the completion of its business combination with Amplitude Healthcare Acquisition Corporation , a special purpose acquisition...

at 16:05
LogicBio Therapeutics, Inc. , a clinical-stage genetic medicine company pioneering gene editing and gene delivery platforms to address rare and serious diseases from infancy through adulthood, today announced that president and chief executive...

at 16:00
The "U.S. Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report by Application (Immunodeficiency Diseases, Multifocal Motor Neuropathy), by Distribution Channel, and Segment Forecasts, 2021-2028" report has been added to...

News published on 29 july 2021 at 14:59 and distributed by: